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Prions, self-propagating protein structures that can be transmitted between cells and different organ-
isms, usually consist of ordered protein aggregates. Alberti et al. (2009) now present a systematic 
approach for the discovery of new prions that expands the spectrum of their biological functions.20 Cell 137, April 3, 2009 ©2009 Elsevier Inc.expressed in yeast, as indicated by the 
formation of puncta in the cells. Fur-
thermore, 50% of the candidate pro-
teins, when purified from yeast cells, 
exhibit resistance to denaturation in 
the presence of sodium dodecyl sul-
fate (SDS), a characteristic property 
of cross-β sheet-rich prions and amy-
loids. In vitro aggregation assays show 
that half of the candidate proteins are 
also able to nucleate and form aggre-
gates within 72 hr, as indicated by the 
ability of the purified proteins to bind to 
the amyloid-binding fluorophore thio-
flavin T. These protein aggregates are 
also SDS resistant, further indicating 
that they are not amorphous but have 
robust quaternary structures such as 
cross-β sheet structures.
To assay whether any of the prion 
domain candidate proteins could be heri-
tably propagated, Alberti and colleagues 
developed an assay based on the trans-
lation termination factor Sup35p, one of 
the best understood functional prions. 
In the aggregated state, Sup35p ceases 
to function, enabling stop codon read-
through. This leads to a [PSI+] cell phe-
notype that can be transmitted to daugh-
ter cells and thus constitutes a means of 
non-Mendelian, protein-based pheno-
type inheritance (Wickner, 1994). Alberti 
et al. fused candidate prion domains 
to the translation termination domain 
of Sup35p. The fusion proteins were 
assayed for their ability to induce Sup35p 
aggregation and promote stop codon 
read-through. The authors find that 22 
of the candidate prion domain-Sup35p 
fusion proteins aggregate and cause 
stop codon read-through. Consistent Alberti and colleagues begin their sys-
tematic approach by searching the yeast 
genome for candidate prion domains. 
The authors use a bioinformatics algo-
rithm (hidden Markov model) based on 
sequence information from the known 
yeast prions Sup35p, Ure2p, and Rnq1p. 
This method is complementary to that 
used in a previous study to survey a 
variety of organisms for the glutamine/
asparagine (Gln/Asn)-rich sequences 
characteristic of yeast prions (Michelitsch 
and Weissman, 2000). As the authors 
acknowledge, basing the algorithm on the 
known yeast prions does result in a bias 
toward finding prion domains with Gln/
Asn-rich motifs. Hence, the approach will 
likely underestimate the number of yeast 
prions, given that some non-Gln/Asn-
based prion domains are known (such 
as the fungal Het-S prion). However, Gln/
Asn-based prion domains are present in a 
large category of important proteins and 
the presence of Gln/Asn-rich sequence 
motifs remains a necessary assumption 
for building sequence-based models of 
prionogenicity.
From their search results, Alberti and 
colleagues closely examined the top 
100 candidate prion domains that are 
greater than 60 residues in length. To 
validate these proteins as prions, the 
authors assessed them for their ability 
to form aggregates in vivo under physi-
ological conditions, for their propensity 
to form amyloid in vitro in the absence 
of the influence of the protein homeo-
stasis (proteostasis) network, and for 
their ability to be heritably propagated 
in cells. Of the top 100 candidate pri-
ons, 69 proteins aggregate when over-Prions are protein aggregates that are 
propagated by the concentration- and 
nucleation-dependent conversion of 
soluble prionogenic proteins into prion 
aggregates that often adopt a cross-β 
sheet-rich (amyloid) structure (Prusiner, 
1998). Given their capacity to propagate 
themselves, prions can be transmitted 
between cells and organisms by mech-
anisms that are only beginning to be 
understood. Indeed, pathological prions 
cause Kuru, a human prion disease asso-
ciated with cannibalism. In this and other 
prion diseases, the aggregated form of 
the prion protein efficiently recruits the 
soluble form of the prion protein into 
the structured aggregate (prion particle), 
enabling propagation. Until relatively 
recently, prions derived from the trans-
lation termination factor Sup35p in the 
budding yeast Saccharomyces cerevisiae 
were the only examples of amyloid-like 
aggregates thought to have normal cellu-
lar functions. However, it is now clear that 
amyloid and amyloid-like aggregates can 
perform a variety of important biological 
functions in addition to their involvement 
in neurodegenerative diseases such as 
Alzheimer’s disease (Fowler et al., 2006). 
Given that functional amyloids have highly 
divergent sequences and that there is a 
paucity of effective tools to identify them, 
we have likely seen only the tip of the 
iceberg. In this issue, Alberti et al. (2009) 
deploy an elegant combination of bioin-
formatics and biological assays to iden-
tify and characterize prion candidates in 
S. cerevisiae, thereby making a significant 
contribution toward understanding new 
prions that have the potential for normal 
cellular functions.
with the known requirements 
for heritable prion propaga-
tion, transmission of these 22 
candidates to daughter cells 
generally requires the prion 
fragmentor protein Hsp104p 
(which breaks up prion aggre-
gates so that daughter cells 
can inherit aggregate seeds) 
and the helper [RNQ+] prion 
(which promotes the aggre-
gation of other prions).
Overall, Alberti et al. con-
firm that 18 of the 100 can-
didate proteins contain bona 
fide prion domains, as char-
acterized by their ability to 
aggregate in vivo, to form 
amyloid in vitro, and to herita-
bly replicate in cells (Figure 1). 
This list of 18 includes known 
yeast prions such as Sup35p, 
Rnq1p, Swi1p, and Ure2p. 
Several new prions, Mca1p 
and Cyc8p, that have since 
been independently reported 
(Patel et al., 2009; Nemecek 
et al., 2009) were also iden-
tified as likely candidates by 
Alberti et al.
Analysis of the prion domain 
sequences also reveals that 
asparagine residues are 
highly enriched among the 
identified aggregation-prone 
prion domains, whereas glu-
tamine-rich sequences occur 
less frequently and thus 
seem less prone to aggre-
gation. This amino-acid bias 
is a remarkable and unex-
pected finding. Further study 
is required to understand this 
result, as it is not immediately 
obvious why sequences rich 
in glutamine residues (with 
an additional CH2 group 
compared to asparagine) 
would be less prionogenic, 
especially given that there 
are numerous polyglutamine 
aggregation diseases, such 
as Huntington’s disease.
In their study, Alberti and colleagues 
also rigorously characterized Mot3p, 
one of the more interesting candidate 
prion proteins. Mot3p is a transcrip-
tion factor that modulates a variety of 
processes, including mating, carbon 
metabolism, and the stress response. 
Alberti et al. demonstrate that Mot3p is 
also a yeast prion in its native environ-
ment. As expected, maintenance of the 
Mot3p prion state requires Hsp104p to 
fragment the amyloid-like 
Mot3p aggregates, promot-
ing inheritance of aggregate 
seeds and thus the prion 
phenotype. The authors find 
that the aggregated state of 
Mot3p influences its regula-
tion of a cell wall remodeling 
program during adaptation 
to anaerobic conditions. This 
indicates that the prion form 
of the protein could confer a 
fitness advantage in certain 
environments.
That the yeast prions iden-
tified in the study of Alberti et 
al. and elsewhere influence 
the processes of transcrip-
tion and translation in the 
cell support the hypothesis 
that prions have normal cel-
lular functions. Furthermore, 
it is possible that prions could 
promote phenotypic vari-
ability within a population of 
cells. The current work not 
only suggests that multiple 
functional prion proteins exist 
in the yeast cell, but that 
these prions share a common 
proteostasis regulatory net-
work consisting of Hsp104p 
and Rnq1p (Balch et al., 
2008). The study underscores 
that, in yeast, the regula-
tory network for proteostasis 
is important in determining 
whether an aggregate can 
be efficiently propagated 
to a daughter cell or not (for 
example, Hsp104p is known 
to be critical for efficient fun-
gal prion propagation) (Cher-
noff et al., 1995) (Figure 1). 
This observation raises ques-
tions about whether nonprop-
agating amyloid diseases and 
propagating prion diseases 
in humans are truly distinct, 
or whether they represent a 
continuum of possibilities dic-
tated by the sequence of the 
peptide, the structure of the aggregate, 
as well as the many activities that com-
prise the proteostasis network and the 
extent to which stress-responsive sig-
naling pathways are activated (Balch et 
al., 2008). Indeed, the amyloid disease 
Figure 1. Systematic Identification of New Prions in Yeast
(Top) To identify functional amyloidogenic or aggregation-prone sequences, 
including prions, in the Saccharomyces cerevisiae genome, Alberti et al. 
(2009) deployed a computational approach. The resulting list of 100 candidate 
proteins that harbor prion-like domains were examined in functional assays 
for their ability to aggregate both in vivo and in vitro as well as to replicate as 
prions in cells. A total of 18 candidate proteins were shown to contain bona 
fide prion domains.
(Bottom) Mot3p was identified as a candidate prion. Mot3p is a transcription-
al repressor of anaerobic genes and influences mating, carbon metabolism, 
stress response, and cell wall adaptation to anaerobic conditions. Alberti et al. 
show that Mot3p aggregation in yeast cells leads to heritable cell wall-related 
phenotypes. The propagation capacity of prions, including Mot3p, is con-
trolled by components of the protein homeostasis network (such as the prion 
fragmentor Hsp104p) and physical properties of the prion aggregate (such as 
the presence of asparagine- or glutamine-rich sequences).Cell 137, April 3, 2009 ©2009 Elsevier Inc. 21
reactive amyloidosis exhibits features 
of a prion disease. Aggregate fibrils 
consisting of serum amyloid A, a pro-
tein whose overexpression in humans 
and other animals can lead to reactive 
amyloidosis, are capable of recruiting 
soluble serum amyloid A in a process 
that appears to spread the amyloid 
throughout the organism (Johan et al., 
1998).
Further study of functional amyloid 
and prions will undoubtedly provide 
insights into the etiology of amyloid and 
prion diseases by educating us about 
the means by which biological systems 
can harness amyloid and prions with-
out deleterious effects from the aggre-
gates. A significant achievement in this 
effort would be the development of a 
general method to characterize amy-22 Cell 137, April 3, 2009 ©2009 Elsevier Inc
Adipose tissue is central to the control 
of energy homeostasis. Although white 
adipose tissue acts primarily as a site of 
fat storage, it also communicates with 
peripheral and central sites in times 
of excess or insufficient food supply 
through the release and action of a vari-
ety of adipokines, including adiponectin 
and leptin (Dahlman and Arner, 2007). 
In contrast, brown adipose tissue pro-
tects against obesity through the action 
of β-adrenergic stimulation and thyroid 
hormone in regulating adaptive thermo-
genesis due to mitochondrial uncou-
pling (Cannon and Nedergaard, 2004). 
Brown adipose tissue has a high den-
sity of mitochondria and elevated oxida-
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The transcriptional coactivator 
programs in brown adipose tiss
negative feedback regulator of Ploid and prions in different organisms 
solely based on their structural and 
functional attributes without regard to 
their sequences. In combining a com-
putational approach with a variety of 
functional assays to identify numer-
ous new prion sequences, the work of 
Alberti et al. has brought us one step 
closer to this goal.
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tor of PGC-1α/PPARδ-mediated brown 
fat metabolism. This regulation controls 
mitochondrial metabolism and uncou-
pling and has implications for energy 
homeostasis in obesity (Figure 1).
Twist-1 is a highly conserved tran-
scription factor that belongs to the 
basic helix-loop-helix (bHLH) family 
of proteins (Thisse et al., 1987). It acts 
as a regulator of various processes 
including early development, apop-
tosis, cancer, and osteoblast differ-
entiation (Sosic and Olson, 2003). In 
humans, a germline mutation in the 
coding sequence of twist-1, which 
results in haploinsufficiency, is respon-
abolism
l biogenesis and thermogenic 
ranscription factor twist-1 as a 
